Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes

Overview

cited authors

Sridhar, Vikas S.; Limonte, Christine P.; Groop, Per-Henrik; Heerspink, Hiddo J. L.; Pratley, Richard E.; Rossing, Peter; Skyler, Jay S.; Cherney, David Z. I.

Publication Date

October 6, 2023

webpage

Web of Science

published in

DIABETOLOGIA Journal

Research

keywords

Cardiorenal
Chronic kidney disease
Glucagon-like peptide 1 receptor agonist
Mechanisms
Review
Sodium-glucose cotransporter-2 inhibitor
Therapeutics
Type 1 diabetes

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.